The patient is an 81 y.o. physician who was referred in October 2007 for consideration of perispinal etanercept treatment by his internist. The patient had been in good general health until about two ...
Tumor necrosis factor-alpha (TNF) is one of a number of systemic and immunomodulating cytokines that generally act to promote acute-phase reactions but can drive degenerative changes when chronically ...
Dianne Haines thinks it is ironic that a drug that is prescribed in Australia to treat arthritis and psoriasis is not available for treatment of stroke or acquired brain injury. "Yes, the drug is ...
New research into the treatment of Alzheimer's disease reports improvement in language abilities using a novel immune-based approach. A video accompanying the research, published today in the open ...
Etanercept injectable solution is available as brand-name drugs. It’s not available as a generic drug. Brand names: Enbrel, Erelzi. Etanercept comes only in the form of an injectable solution. It ...
Please provide your email address to receive an email when new articles are posted on . To determine the efficacy of monotherapy with either methotrexate or etanercept (Enbrel, Amgen), as well as ...
An extraordinary new scientific study, which for the first time documents marked improvement in Alzheimer’s disease within minutes of administration of a therapeutic molecule, has just been ...
An Australian family is pushing for a controversial new stroke treatment to be made available in Australia, saying the results have been life-changing for their son. Off-label use means using a drug ...
A single injection, then a five-minute wait. That's all it took for hundreds of stroke and traumatic brain injury patients nationwide to reverse years of debilitation. Now they're walking more ...
Please provide your email address to receive an email when new articles are posted on . Approximately 70% of patients with juvenile idiopathic arthritis who are re-treated with etanercept achieve ...
Rituximab in combination with methotrexate is recommended as an option for the treatment of adults with severe active rheumatoid arthritis who have had an inadequate response to, or are intolerant of, ...